Theraclion SA (ALTHE.PA)

1.05 €

+0.05 (+5.00%)
Rating:
Recommendation:
-
Symbol ALTHE.PA
Price 1.05 €
Beta 0.734
Volume Avg. 0.01M
Market Cap 30.133M
Shares () -
52 Week Range 0.91-1.9
1y Target Est -
DCF Unlevered ALTHE.PA DCF ->
DCF Levered ALTHE.PA LDCF ->
ROE 311.54% Strong Buy
ROA -40.44% Strong Sell
Operating Margin -
Debt / Equity -950.96% Strong Sell
P/E -
P/B -12.58 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. David Caumartin
Healthcare
Medical Devices
Paris

Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.